Skip to main content
An official website of the United States government
Español

humanized monoclonal antibody MEDI-522

(HYOO-muh-nized MAH-noh-KLOH-nul AN-tee-BAH-dee …)
A substance being studied in the treatment of some types of cancer and other conditions. Humanized monoclonal antibody MEDI-522 binds to a protein on the surface of blood vessels and may prevent the growth of new blood vessels that tumors need to grow. It may also prevent the spread of cancer. It is a type of antiangiogenesis agent, a type of metastasis inhibitor, and a type of monoclonal antibody. Also called Abegrin, etaracizumab, and MEDI-522.
Search NCI's Dictionary of Cancer Terms